A randomized comparative trial of first-dose response to Angiotensin- Converting Enzyme Perindopril and Captopril in Indonesian heart failure patients
Several large placebo-controlled trials have confirmed that angiotensin converting enzyme (ACE) inhibitors significantly reduce mortality aid morbidity in all functional grades of congestive heart failure (CHF), nevertheless only a proportion of patients who may benefit from treatment are priscribe...
Main Authors: | Lukman H. Makmun, Nurhay Abdurachman, Idrus Alwi, Dedi Afandi, Bambang B. Siswanto, Hananto Andriantoro, Endang Ratnaningsih, Hari Utomo |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine Universitas Indonesia
2002-02-01
|
Series: | Medical Journal of Indonesia |
Online Access: | http://mji.ui.ac.id/journal/index.php/mji/article/view/45 |
Similar Items
-
Perindopril - angiotensin-converting enzyme inhibitor is approved for usage
by: D A Napalkov
Published: (2014-12-01) -
The role of the renin-angiotensin system in responsiveness to captopril treatment
by: Bakhit, Dana M.
Published: (2003) -
Retinal angiotensin II and angiotensin-(1-7) response to hyperglycemia and an intervention with captopril
by: Preenie deS Senanayake, et al.
Published: (2018-08-01) -
Perindopril is angiotensin-converting enzyme inhibitor in treatment patients with arterial hypertension
by: A I Martynov, et al.
Published: (2014-09-01) -
Principles of choice of an angiotensin-converting enzyme inhibitor: Specific features of perindopril
by: T E Morozova, et al.
Published: (2014-09-01)